Skopos Labs, Inc. Legend Biotech Corp Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,725 shares of LEGN stock, worth $49,041. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,725
Previous 142
1114.79%
Holding current value
$49,041
Previous $4,000
1350.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$197 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$191 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$170 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$163 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$107 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $4.76B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...